According to most shareholders, hedge funds are assumed to be slow, outdated investment vehicles of the past. While there are over 8000 funds trading at present, we look at the moguls of this group, around...... (read more)

It’s not easy being a biotech company. Every year, the biotech industry pours billions of dollars in research and development costs towards creating cutting edge drugs that treat major diseases. If...... (read more)

What: Shares of molecular diagnostics company Myriad Genetics, Inc. (NASDAQ:MYGN) fell as much as 13% following yesterday's mixed U.S. Supreme Court ruling on gene patents and a flurry of analyst upgrades...... (read more)

Forrester Research, Inc. (NASDAQ:FORR) was in 11 hedge funds' portfolio at the end of March. FORR has seen a decrease in hedge fund interest lately. There were 12 hedge funds in our database with FORR...... (read more)

On June 30, the Supreme Court is going to make a decision on a case filed by the Association for Molecular Biology on human genome patentability against Myriad Genetics, Inc. (NASDAQ:MYGN), a $2.57...... (read more)

Myriad Genetics, Inc. (NASDAQ:MYGN) was in 19 hedge funds' portfolio at the end of March. MYGN has experienced a decrease in enthusiasm from smart money in recent months. There were 21 hedge funds in...... (read more)

I admit to not being a big fan of many of her movies -- possibly the only man on the planet who will admit so -- but there's little denying that movie sensation Angelina Jolie has a history of selfless...... (read more)

Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot by options volume’ market...... (read more)

Sony Corporation (ADR) (NYSE:SNE) – Big prints in Sony Corporation (ADR) (NYSE:SNE) call and put options this morning pushed the consumer electronics maker onto our ‘hot by options volume’ market...... (read more)